First Venture Sweden

1.39 SEK

+4.92 %

Less than 1K followers

FIRST B

First North Stockholm

Investment

Financials

Overview

Financials & Estimates

Ownership

Investor consensus

+4.92 %

+1.22 %

-21.65 %

-19.14 %

-21.43 %

-28.89 %

-67.94 %

-

-82.67 %

First Venture Sweden is an investment company. The company specializes in investment, ownership and further management of companies operating primarily in technology, health and sustainability. The largest share of investments is found in global macro trends and themes such as digitalization, sustainable consumption and health and climate. First Venture Sweden was founded in 2006 and is headquartered in Stockholm.

Market cap

77.96M SEK

Turnover

33.4K SEK

Revenue

-

EBIT %

-

P/E

-

Dividend yield-%

-

Revenue and EBIT-%

Revenue K

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar

19/2

2026

Annual report '25

All

Press releases

3rd party

ShowingAll content types

Regulatory press releaseyesterday

First Venture Sweden AB offentliggör utfallet i bolagets företrädesemission

First Venture Sweden

Regulatory press release12/8/2025, 2:45 PM

First Venture Sweden AB substansvärde per 30 november 2025

First Venture Sweden

Press release12/1/2025, 10:15 AM

First Venture Sweden AB: Styrelseledamoten Karl Brodin och Andreas Lindenhierta tecknar sig för sin pro rata andel i pågående nyemission

First Venture Sweden

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Press release11/28/2025, 2:50 PM

Analyst Group: Aktieanalys på First Venture - Stärkt kassa och strategiska investeringar lägger grunden för tillväxt

First Venture Sweden

Regulatory press release11/25/2025, 10:30 AM

First Venture Sweden AB offentliggör informationsmemorandum i samband med företrädesemission

First Venture Sweden

Regulatory press release11/25/2025, 10:25 AM

First Venture Sweden AB:s TF VD kommenterar motivet till företrädesemissionen och bolagets framtidsutsikter

First Venture Sweden

Press release11/24/2025, 1:15 PM

First Venture Sweden AB: Sprint Bioscience har sålt sitt cancerprogram TREX1 och värdet för CombiQ justeras sannolikt ned

First Venture Sweden

Regulatory press release11/24/2025, 1:00 PM

First Venture Sweden AB - Kommuniké från extra bolagsstämma

First Venture Sweden

Press release11/7/2025, 2:19 PM

Analyst Group: Analyst Group kommenterar First Ventures Q3-rapport

First Venture Sweden

Regulatory press release11/6/2025, 6:35 AM

Kallelse till extra bolagsstämma i First Venture Sweden AB

First Venture Sweden

Regulatory press release11/6/2025, 6:30 AM

Styrelsen i First Venture Sweden AB har beslutat om en företrädesemission om cirka 24,95 miljoner kronor, villkorat av bolagsstämmans efterföljande godkännande

First Venture Sweden

Regulatory press release11/4/2025, 5:00 PM

First Venture Sweden AB (publ) – Delårsrapport januari – september 2025 Q3.

First Venture Sweden

Regulatory press release10/31/2025, 3:00 PM

First Venture Sweden AB

First Venture Sweden

Regulatory press release9/25/2025, 4:00 PM

First Venture Sweden AB: Andreas Lindenhierta utses till tillförordnad VD

First Venture Sweden

Press release9/18/2025, 1:30 PM

Intervju med Lars Birging – VD på ZIGRID.se First Ventures

First Venture Sweden

Press release9/15/2025, 2:10 PM

First Venture substansvärde

First Venture Sweden

Press release8/29/2025, 8:15 AM

First Venture substansvärde

First Venture Sweden

Press release8/26/2025, 8:57 AM

Analyst Group: Aktieanalys på First Venture - Omotiverad substansrabatt men finansieringsfrågan består

First Venture Sweden

Press release8/22/2025, 6:30 AM

Analyst Group: Analyst Group kommenterar First Ventures Q2-rapport

First Venture Sweden

Regulatory press release8/21/2025, 9:05 AM

Minskat substansvärde men ökad börskurs– Halvårsrapport januari – juni 2025.

First Venture Sweden

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.